Benzinga
05 Feb 2026, 15:18 UTC · 31w ago
Verdict
Headline leans bullish. We score CAH +1.00 across four claims.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+1.00strongly bullish
What the story claims
4 claims · scored −1 bearish … +1 bullish
Cardinal Health raised its fiscal year 2026 adjusted earnings per share guidance to $10.15–$10.35, up from at least $10.
More positive than 98% of claims this week
The company reported adjusted earnings of $2.63 per share and sales of $65.63 billion, beating consensus estimates of $2.35 and $64.14 billion respectively.
Continue reading
5 related stories
More positive than 99% of ticker scores this week
Scored by the NIS engine · methodology.
More positive than 91% of claims this week
The Global Medical Products and Distribution segment profit increased 106% to $37 million, driven by cost optimization and volume growth.
So whatTriple-digit profit growth in a specific segment indicates successful margin expansion and efficiency gains.
More positive than 77% of claims this week
Pharmaceutical and Specialty Solutions segment profit grew 29% to $687 million, with guidance for the segment profit growth raised to 20%–22%.
More positive than 65% of claims this week
Which stocks this story touches
More positive than 99% of ticker scores this week
The company reported earnings and sales that beat consensus, raised its fiscal 2026 outlook, and hit a 52-week high.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
WSJ
1h ago
+12.4%
Price agrees with the score
$232.54 vs $206.85 close before publication (Feb 4) · not market-adjusted
CAH chart →
